IL10 and type 1 diabetes mellitus: Tolerogenic vaccination with antigen-loaded tolDCs engineered to express IL-10 suppressed disease in mouse models of T1D and asthma (98, 99), and antigen-loaded tolDCs cultured in presence of IL-10 reduced disease in EAE (100).